Skip to main content
UniHealth

Doctor search

Brian Michael Brady, MD

Nephrology · Stanford

NPI 1902190721

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
17
3 carriers
Offices
3

Offices

3 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: 552672 · 552698 · Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plans that list them

17 plans · 3 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Brady’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

17 of 17 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A136657 · Current

Licensed to practise in California · since 2015 · expires 2026-10-31 · Jefferson Medical College of Thomas Jefferson University.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$96,020

Medicare paid this office $96,020 for 421 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Return visit (30+ min)199$23,230$98
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes42$12,844$106
Long return visit (40+ min)62$12,582$140
New patient visit (60+ min)65$10,142$156
Dialysis services, 1 physician visit per month (20 years or older)14$9,356$187
See all 10 services
Every Original Medicare service billed
Return visit (30+ min)199$23,230$98
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes42$12,844$106
Long return visit (40+ min)62$12,582$140
New patient visit (60+ min)65$10,142$156
Dialysis services, 1 physician visit per month (20 years or older)14$9,356$187
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes43$5,784$71
Return visit (30+ min)34$3,051$76
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes20$2,447$117
Telephone medical discussion with physician, 21-30 minutes13$1,631$117
Hemodialysis procedure with physician evaluation12$758$63

Who their Medicare patients are

421 Original Medicare patients in 2024. Average age 74 · Under 65 13% · 85 and older 16% · Women 48% · Also on Medicaid 26% · Health risk score 3.13. At or below the middle of the specialty; the typical nephrology clinician is at 4.01.

Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 51% · Coronary heart disease 41% · Heart failure 35% · Atrial fibrillation 30% · Cancer 24% · Depression 20% · COPD 17% · Stroke 16% · Dementia 12%.

The office billed $403,639, Medicare allowed $127,948 and paid $96,020; for 838 services of 20 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024421838743.13$403,639$96,020
2023399806733.61$381,759$83,182
2022408924733.44$443,188$86,637
2021365954713.63$486,879$93,002
20203931,993724.43$370,101$151,594
20193883,041743.84$368,115$238,929
20182372,092743.11$162,708$121,319
201540116654.22$21,435$9,176
20143284602.58$14,905$6,485

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 10 services

Original Medicare services billed in 2023
Return visit (30+ min)130$13,471$79
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes65$10,068$73
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes32$9,544$110
Return visit (30+ min)88$8,451$80
Long return visit (40+ min)43$7,273$128
New patient visit (60+ min)44$6,642$151
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes39$4,663$120
Long return visit (40+ min)20$3,700$119
New patient visit (60+ min)21$2,614$124
Hemodialysis procedure with physician evaluation11$787$66

2022: 13 services

Original Medicare services billed in 2022
Return visit (30+ min)112$13,700$78
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes53$12,344$94
Return visit (30+ min)91$12,234$82
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes86$10,600$65
New patient visit (60+ min)51$7,537$148
New patient visit (60+ min)31$4,332$140
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes34$4,197$123
Long return visit (40+ min)16$3,682$127
Long return visit (40+ min)18$3,163$132
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes23$2,082$91
Dialysis procedure including 1 evaluation12$1,540$81
Hemodialysis procedure with physician evaluation11$936$67
Short return visit (20+ min)15$799$53

2021: 13 services

Original Medicare services billed in 2021
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes89$15,137$66
Return visit (30+ min)106$14,351$84
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes49$10,171$95
New patient visit (60+ min)60$9,683$161
New patient visit (60+ min)51$8,264$162
Long return visit (40+ min)31$5,250$125
Dialysis procedure including 1 evaluation15$4,805$81
Return visit (30+ min)37$4,605$81
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes27$3,369$125
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes32$3,119$92
Dialysis services, 1 physician visit per month (20 years or older)11$2,842$189
Long return visit (40+ min)14$2,607$130
Hemodialysis procedure with physician evaluation22$2,486$67

2020: 17 services

Original Medicare services billed in 2020
Dialysis services, 4 or more physician visits per month (20 years or older)39$41,069$254
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes142$38,081$66
Return visit (30+ min)108$12,750$86
Initial hospital care with moderate level of medical decision making at least 75 minutes52$11,553$178
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes36$6,327$94
Hemodialysis procedure with physician evaluation46$5,680$67
Dialysis procedure including 1 evaluation21$5,631$82
Injection, epoetin alfa, (for non-esrd use), 1000 units17$4,316None
Dialysis services, 2-3 physician visits per month (20 years or older)18$4,286$195
New patient visit (60+ min)21$3,179$151
Return visit (30+ min)32$2,963$74
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes29$2,761$95
New patient visit (60+ min)17$2,687$158
New patient visit (45+ min)22$2,658$121
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes13$1,671$129
Long return visit (40+ min)14$1,469$105
Injection of drug or substance under skin or into muscle17$452$12

2019: 12 services

Original Medicare services billed in 2019
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes161$57,865$64
Dialysis services, 4 or more physician visits per month (20 years or older)41$44,917$254
Return visit (30+ min)181$38,669$95
Dialysis services, 2-3 physician visits per month (20 years or older)42$31,050$210
Initial hospital care with moderate level of medical decision making at least 75 minutes102$24,086$178
New patient visit (60+ min)62$11,447$185
Injection, epoetin alfa, (for non-esrd use), 1000 units28$7,956None
Hemodialysis procedure with physician evaluation47$6,721$65
Dialysis services, 1 physician visit per month (20 years or older)25$6,710$164
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes25$3,215$89
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes13$1,685$120
Injection of drug or substance under skin or into muscle27$1,071$15

2018: 9 services

Original Medicare services billed in 2018
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes79$36,276$64
Dialysis services, 2-3 physician visits per month (20 years or older)30$21,566$211
Return visit (30+ min)108$18,065$97
Initial hospital care with moderate level of medical decision making at least 75 minutes55$11,414$176
Injection, epoetin alfa, (for non-esrd use), 1000 units17$9,708None
New patient visit (60+ min)40$7,390$185
Dialysis services, 1 physician visit per month (20 years or older)21$6,584$165
Dialysis services, 4 or more physician visits per month (20 years or older)14$6,017$251
Injection of drug or substance under skin or into muscle17$1,081$20

2015: 3 services

Original Medicare services billed in 2015
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes27$3,617$58
Initial hospital care with moderate level of medical decision making at least 75 minutes19$3,178$167
Hospital discharge day management, 30 minutes or less20$1,182$59

2014: 2 services

Original Medicare services billed in 2014
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes15$2,382$60
Hospital discharge day management, 30 minutes or less11$659$60

Medicaid work

$883 in 2024

Medicaid paid $883 for 17 billed services this clinician did in 2024, up to 12 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES17$883
Medicaid work by year
202417112$883
2023193220$6,164
2022171215$5,614
2021170219$5,110
2020738323$40,219
2019104422$9,775
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES163$5,149
Return visit (30+ min)30$1,015

2022

Largest Medicaid services in 2022
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES103$2,913
Return visit (30+ min)68$2,701

2021

Largest Medicaid services in 2021
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES144$4,074
Return visit (30+ min)26$1,036

2020

Largest Medicaid services in 2020
End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month123$24,997
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES575$13,725
Return visit (30+ min)40$1,497

2019

Largest Medicaid services in 2019
End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month38$6,868
End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month12$1,708
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES38$609
Return visit (30+ min)16$591

Drugs they prescribed that Part D paid

$376,672

Pharmacies billed $376,672 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

706 generic and 336 brand-name prescriptions · $376,672 in drug cost · 11 antibiotic prescriptions to 11 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Farxiga201$193,313$962
Jardiance55$43,306$787
Lokelma23$15,089$656
Dapagliflozin11$9,606$873
Sevelamer Carbonate19$3,582$189
See all 24 drugs
Every Part D drug this clinician prescribed
Farxiga201$193,313$962
Jardiance55$43,306$787
Lokelma23$15,089$656
Dapagliflozin11$9,606$873
Sevelamer Carbonate19$3,582$189
Eplerenone16$2,145$134
Chlorthalidone76$1,255$17
Calcium Acetate14$1,007$72
Bumetanide17$680$40
Losartan71$630$9
Calcitriol18$531$30
Furosemide45$413$9
Olmesartan Medoxomil14$386$28
Tamsulosin17$385$23
Amlodipine Besylate58$339$6
Telmisartan17$327$19
Carvedilol35$268$8
Gabapentin17$231$14
Allopurinol16$171$11
Lisinopril40$132$3
Spironolactone18$94$5
Prednisone11$81$7
Atorvastatin22$43$2
Atenolol12$21$2

Year by year

Part D prescribing by year
20241,042202None32%$376,672
20239291760% (0)30%$275,059
20229571580% (0)35%$256,516
20216471500% (0)30%$147,118
2020749104None21%$125,483
2019890116None28%$77,708
2018159540% (0)11%$5,738
2015662217% (11)None$1,723
201431838None24%$20,076
201346855NoneNone$19,735

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 20 drugs

Part D drugs prescribed in 2023
Farxiga173$169,878$982
Jardiance28$29,592$1,057
Clinolipid14$5,363$383
Chlorthalidone94$1,869$20
Calcium Acetate18$1,313$73
Bumetanide17$1,215$71
Losartan74$1,011$14
Potassium Chloride13$942$72
Amlodipine Besylate46$807$18
Calcitriol18$660$37
Hydralazine18$404$22
Furosemide33$378$11
Lisinopril40$326$8
Allopurinol31$321$10
Gabapentin11$235$21
Prednisone26$206$8
Triamterene-Hydrochlorothiazid13$132$10
Atenolol16$129$8
Spironolactone16$104$7
Carvedilol20$85$4

2022: 19 drugs

Part D drugs prescribed in 2022
Farxiga164$126,641$772
Jardiance24$22,834$951
Veltassa15$22,240$1,483
Procrit18$19,187$1,066
Prosol36$18,077$502
Eliquis11$8,150$741
Cyclophosphamide14$3,594$257
Chlorthalidone113$2,466$22
Calcitriol53$1,618$31
Losartan72$1,026$14
Calcium Acetate18$794$44
Bumetanide17$730$43
Carvedilol41$607$15
Furosemide49$470$10
Allopurinol25$448$18
Amlodipine Besylate48$399$8
Lisinopril47$183$4
Metoprolol11$109$10
Famotidine16$103$6

2021: 14 drugs

Part D drugs prescribed in 2021
Farxiga84$60,112$716
Renvela12$27,315$2,276
Veltassa17$16,526$972
Chlorthalidone71$1,915$27
Calcitriol45$1,540$34
Losartan75$971$13
Furosemide53$448$8
Allopurinol23$406$18
Amlodipine Besylate27$293$11
Carvedilol16$238$15
Hydralazine15$229$15
Lisinopril32$164$5
Prednisone12$72$6
Tamsulosin13$41$3

2020: 18 drugs

Part D drugs prescribed in 2020
Renvela27$30,438$1,127
Prosol69$21,206$307
Sevelamer Carbonate47$19,191$408
Calcium Acetate31$2,719$88
Calcitriol44$2,148$49
Chlorthalidone51$2,084$41
Metoprolol31$1,238$40
Hydralazine35$865$25
Furosemide50$537$11
Allopurinol27$533$20
Amlodipine Besylate50$407$8
Midodrine16$401$25
Lisinopril53$229$4
Carvedilol26$184$7
Losartan13$161$12
Clonidine17$129$8
Hydrochlorothiazide11$88$8
Metoprolol13$38$3

2019: 21 drugs

Part D drugs prescribed in 2019
Renvela13$18,905$1,454
Prosol75$17,455$233
Sevelamer Carbonate32$5,754$180
Intralipid45$4,761$106
Chlorthalidone73$3,070$42
Calcitriol39$1,691$43
Calcium Acetate26$1,186$46
Metoprolol23$1,060$46
Furosemide120$920$8
Dextrose in Water46$813$18
Hydralazine34$775$23
Amlodipine Besylate63$438$7
Allopurinol11$417$38
Gabapentin26$381$15
Lisinopril54$285$5
Doxazosin Mesylate11$248$23
Midodrine13$237$18
Carvedilol19$236$12
Losartan16$224$14
Prednisone12$110$9
Metoprolol12$95$8

2018: 4 drugs

Part D drugs prescribed in 2018
Calcitriol20$814$41
Furosemide35$189$5
Amlodipine Besylate17$109$6
Lisinopril13$62$5

2015: 1 drug

Part D drugs prescribed in 2015
Omeprazole15$114$8

2014: 8 drugs

Part D drugs prescribed in 2014
Lantus Solostar25$8,467$339
Hydralazine12$197$16
Omeprazole29$176$6
Isosorbide Mononitrate Er14$76$5
Clopidogrel17$63$4
Lisinopril14$59$4
Furosemide20$57$3
Amlodipine Besylate15$40$3

2013: 12 drugs

Part D drugs prescribed in 2013
Lantus Solostar15$4,140$276
Clonidine13$2,133$164
Proair Hfa18$814$45
Atorvastatin14$479$34
Amlodipine Besylate35$197$6
Klor-Con M2015$195$13
Omeprazole28$184$7
Carvedilol23$89$4
Isosorbide Mononitrate Er11$79$7
Hydrochlorothiazide25$69$3
Digox13$54$4
Furosemide20$54$3

Money from drug and device companies

$1,288 in 2024

Industry payments by year
202418None$1,288
202311None$3

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
AstraZeneca Pharmaceuticals LPNone$1,288
8 payments
  • Meals · 2024-06-11 · $35
  • Travel · 2024-06-11 · $38
  • Meals · 2024-06-11 · $50
  • Meals · 2024-06-11 · $35
  • Travel · 2024-06-11 · $708
  • Meals · 2024-06-11 · $40
  • Travel · 2024-06-11 · $205
  • Travel · 2024-06-11 · $178
See all 8 published payments
Every published payment
AstraZeneca Pharmaceuticals LPMeals · 2024-06-11None$35
AstraZeneca Pharmaceuticals LPTravel · 2024-06-11None$38
AstraZeneca Pharmaceuticals LPMeals · 2024-06-11None$50
AstraZeneca Pharmaceuticals LPMeals · 2024-06-11None$35
AstraZeneca Pharmaceuticals LPTravel · 2024-06-11None$708
AstraZeneca Pharmaceuticals LPMeals · 2024-06-11None$40
AstraZeneca Pharmaceuticals LPTravel · 2024-06-11None$205
AstraZeneca Pharmaceuticals LPTravel · 2024-06-11None$178
See earlier years (2023)

2023: $3

Payments by company in 2023
Travere TherapeuticsNone$3
1 payment
  • Education · 2023-10-04 · $3

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
AstraZeneca Pharmaceuticals LP · A Phase 3,Randomised,Double Blind,Active Controlled Study To Assess the Efficacy,Safety and Tolerability of Baxdrostat in Combination With Dapagliflozin Compared With Dapagliflozin Alone on Chronic Kidney Disease Ckd Progression in Participants With Ckd and High Blood Pressure · 2025Their institution$87,244

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1902190721
Licence
CA A136657California A136657: Current · expires 2026-10-31
Trained
Jefferson Medical College of Thomas Jefferson University, 2011
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207RN0300X (207RN0300X); Internal medicine (207R00000X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2011-06-09
NPI last updated
2024-04-17
NPI record certified
2024-04-17

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 3322 N Broad St, Philadelphia, PA, 19140